Edition:
United Kingdom

Sellas Life Sciences Group Inc (SLS.OQ)

SLS.OQ on NASDAQ Stock Exchange Capital Market

4.94USD
23 Apr 2018
Change (% chg)

$-0.44 (-8.18%)
Prev Close
$5.38
Open
$5.40
Day's High
$5.41
Day's Low
$4.81
Volume
27,960
Avg. Vol
80,893
52-wk High
$19.74
52-wk Low
$3.43

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

People

Name Age Since Current Position

Angelos Stergiou

2017 President, Chief Executive Officer, Director

Gene Mack

2018 Chief Financial Officer, Treasurer

Nicholas Sarlis

2017 Chief Medical Officer, Senior Vice President

Gregory Torre

2017 Chief Regulatory Officer, Senior Vice President

John Burns

2017 Vice President - Finance, Corporate Controller
» More People

Sellas Life Sciences Group Inc News

» More SLS.OQ News